Merck Covid-19 antiviral lowered hospitalization rates in the unvaccinated

Merck will look for emergency situation permission for its oral Covid treatment after “engaging outcomes” in trials. CNBC’s Meg Tirrell reports. For access to live and special video from CNBC register for CNBC PRO: https://cnb.cx/2NGeIvi
.
” Register For CNBC TELEVISION: https://cnb.cx/SubscribeCNBCtelevision
” Register for CNBC: https://cnb.cx/SubscribeCNBC
” Sign Up For CNBC Classic: https://cnb.cx/SubscribeCNBCclassic
.
Rely On CNBC television for the current stock exchange news and analysis. From market futures to live cost updates CNBC is the leader in organization news worldwide.

The News with Shepard Smith is CNBC’s day-to-day news podcast supplying deep, non-partisan protection and viewpoint on the day’s crucial stories. Readily available to listen by 8: 30 pm ET/ 5: 30 pm PT everyday start September 30: https://www.cnbc.com/2020/09/29/ the-news-with-shepard-smith-podcast. html? __ source= youtube% 7Cshepsmith% 7Cpodcast
.
Get In Touch With CNBC News Online
Get the most recent news: http://www.cnbc.com/
Follow CNBC on LinkedIn: https://cnb.cx/LinkedInCNBC
Follow CNBC News on Facebook: https://cnb.cx/LikeCNBC
Follow CNBC News on Twitter: https://cnb.cx/FollowCNBC
Follow CNBC News on Instagram: https://cnb.cx/InstagramCNBC

https://www.cnbc.com/select/best-credit-cards/
.
#CNBC
#CNBCTV.

http://covid19globalcases.com/merck-covid-19-antiviral-lowered-hospitalization-rates-in-the-unvaccinated/